Latest News
Europe Human Papillomavirus Vaccine Market to Reach USD 1,598.81m by 2028, According to Research and Markets
27 January 2023 - - The Europe human papillomavirus vaccine market is expected to grow from USD 1,202.66m in 2022 to USD 1,598.81m by 2028; it is estimated to grow at a CAGR of 4.9% from 2022 to 2028, according to a new report from Dublin-based Resea...
Syros Receives Fast Track Designation from US FDA for Tamibarotene for the Treatment of Higher-Risk Myelodysplastic Syndrome
27 January 2023 - - The United States Food and Drug Administration has granted Fast Track Designation to tamibarotene for the treatment of higher-risk myelodysplastic syndrome (HR-MDS), US-based biopharmaceutical company Syros Pharmaceuticals, Inc. (...
Scientist.com Launches SoftServ, a Suite of Software Development and Auditing Services for Life Science Research Companies
27 January 2023 - - US-based biopharma industry R&D marketplace Scientist.com has launched SoftServ, a suite of software services for the life science industry, the company said.

SoftServ's capabilities include full stack softwa...
BioArctic reports EMA acceptance of MAA for lecanemab in early Alzheimer's disease
27 January 2023 - Swedish research-based biopharma company BioArctic AB (STO:BIOA-B) reported on Friday that the European Medicines Agency (EMA) has accepted a marketing authorisation application (MAA) submitted by its partner Eisai Co Ltd (TYO:4523)...
Sanofi and Regeneron's Dupilumab recommended for expanded EU approval
27 January 2023 - French healthcare company Sanofi SA (Euronext Paris:SAN) (Nasdaq:SNY) said on Friday that Dupixent (dupilumab) has been recommended by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for ex...